This study is investigating how the medication Empagliflozin affects the heart's structure and function in patients with heart disease. Empagliflozin is already used to treat diabetes and heart conditions, and this research aims to see if it can help improve heart remodeling, which may lead to better heart health and quality of life. Participants will receive the medication and have regular check-ups to monitor their progress. The study is carefully designed to ensure participant safety. If you have heart disease and want to learn more, please contact (hany\_barsoum@med.asu.edu.eg).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
left ventricular remodeling
Timeframe: 6 months
left ventricular systolic function
Timeframe: 6 months
left ventricular Global Longitudinal Strain (GLS)
Timeframe: 6 months